Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-08-04

FDA Approved: LOVASTATIN — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves Lupin Pharmaceuticals' supplemental application for Lovastatin (generic statin). The approval pertains to changes under the ANDA for this generic p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lovastatin (Lovastatin)

Snippet

SUPPL AP for LOVASTATIN (LOVASTATIN)